Advertisement

Measurement of cellular proliferation within the vitreous during experimental proliferative vitreoretinopathy

  • Chung-May Yang
  • Karl R. Olsen
  • Eleut Hernandez
  • Scott W. Cousins
Laboratory Investigations

Abstract

Cellular proliferation is an important component in the pathogenesis of complex retinal detachments caused by proliferative vitreoretinopathy (PVR). We used flow cytometry to measure the proliferation of cells recovered from the vitreous cavity in an experimental model of tractional retinal detachment induced by homologous fibroblast injection. Two distinct populations of cells were detected. One population comprised smaller, dense cells representing mostly leukocytes. A second population of larger cells contained not only the injected fibroblasts but also high concentrations of host-derived cells with significant proliferative activity, whose number increased for 3 days following injection. Flow cytometry was useful for analysis of the recovered cells for concentration, morphologic features and proliferation. This technique may be applicable in the identification of patients at high risk for the development of PVR.

Keywords

Public Health High Risk Flow Cytometry Dense Cell Experimental Model 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Blumenkranz M, Hernandez E, Ophir A, Norton FWD (1984) 5-Fluorouracil: New applications in complicated retinal detachment for an established antimetabolite. Ophthalmology 91:122–130Google Scholar
  2. 2.
    Blumenkranz MS, Hartzen MK, Hajek AS (1987) Selection of therapeutic agents for intraocular proliferative disease: II. Differing antiproliferative activity of the fluoropyrimidines. Arch Ophthalmol 105:396–399Google Scholar
  3. 3.
    Braunstein JD, Melamed MR, Sharpless TK (1976) Quantitation of lymphocyte proliferation in response to alloantigeneic cells and phytohemagluttinin by flow cytometry: II. Comparison with [14C]-thymidine incorporation. Clin Immunol Immunopathol 5:326–334Google Scholar
  4. 4.
    Butcher EC, Weissman IL (1980) Direct fluorescent labelling of cells with fluorescein or rhodamine isothiocynate: I. Technical aspects. J Immunol Methods 37:97–108Google Scholar
  5. 5.
    Chandler DB, Quansah FA, Hida T, Machemer R (1986) A refined experimental model for proliferative vitreoretinopathy. Graefe's Arch Clin Exp Ophthalmol 224:86–91Google Scholar
  6. 6.
    Constable I (1987) Biological and therapeutic aspects of proliferative vitreoretinopathy. Jpn J Ophthalmol 31:513–520Google Scholar
  7. 7.
    Cotner T, Williams JM, Christenson L, Shapiro H, Strom TB, Strominger J (1983) Simultaneous flow cytometric analysis of human T cell activation, antigen expression and DNA content. J Exp Med 157:461–466Google Scholar
  8. 8.
    Cousins SW, Streilein JW (1990) Flow cytometric detection of lymphocyte proliferation in eyes with immunogenic inflammation. Invest Ophthalmol Vis Sci 31:2111–2122Google Scholar
  9. 9.
    Fastenberg DM, Diddie KR, Dorey K, Ryan SJ (1982) The role of cellular proliferation in an experimental model of massive periretinal proliferation. Am J Ophthalmol 93:565–572Google Scholar
  10. 10.
    Glaser B, Lemos M (1989) Pathobiology of proliferative vitreoretinopathy. In: Ryan SJ (ed) Retina, vol 3. Mosby, St. Louis, pp 369–383Google Scholar
  11. 11.
    Glaser BM, Cardin A, Briscoe B (1987) Proliferative vitreoretinopathy — the mechanisms of development of vitreoretinal traction. Ophthalmology 94:327–332Google Scholar
  12. 12.
    Hatchell DL, McAdoo T, Sheta S, King RT, Bartolome JV (1988) Quantification of cellular proliferation in experimental proliferative vitreoretinopathy. Arch Ophthalmol 106:669–672Google Scholar
  13. 13.
    Hitchins CA, Crierson I, Hiscott PS (1985) The effects of injections of cultured fibroblasts into the rabbit vitreous. Graefe's Arch Clin Exp Ophthalmol 223:237–249Google Scholar
  14. 14.
    Joondeph BC, Khoobehi B, Peyman GA, Yue BY (1988) Liposome-encapsulated 5-fluorouracil in the treatment of proliferative vitreoretinopathy. Ophthalmic Surg 19:252–256Google Scholar
  15. 15.
    Laque H, Machemer R (1975)Glial cell proliferation in retinal detachment (massive periretinal proliferation). Am J Ophthalmol 80:602–618Google Scholar
  16. 16.
    LePecq J-B, Paoletti C (1967) A fluorescent complex between ethidium bromide and nucleic acids. J Mol Biol 27:87–92Google Scholar
  17. 17.
    Machemer R (1988) Proliferative vitreoretinopathy (PVR): a personal account of its pathogenesis and treatment. Invest Ophthalmol Vis Sci 29:1771–1783Google Scholar
  18. 18.
    Machemer R, Laque H (1975) Pigment epithelial proliferation in retinal detachment (massive periretinal proliferation). Am J Ophthalmol 80:1–23Google Scholar
  19. 19.
    Pang MP, Peyman GA, Nikoleit J, Fiscella R, Kao G (1986) Intravitreal trifluorothymidine and retinal toxicity. Retina 260–263Google Scholar
  20. 20.
    Pardee AB (1989) G1 events and the regulation of cell proliferation. Science 246:603–605Google Scholar
  21. 21.
    Radtke ND, Tanno Y, Chandler D, Machemer R (1981) Simulation of massive periretinal proliferation by autotransplantation of retinal pigment epithelial cells in rabbits. Am J Ophthalmol 91:76–87Google Scholar
  22. 22.
    Radtke ND, Weinsicder AD, Ballou RJ (1986) Pharmacological therapy for proliferative vitreoretinopathy. Graefe's Arch Clin Exp Ophthalmol 224:230–233Google Scholar
  23. 23.
    Ryan SJ (1985) The pathophysiology of proliferative vitreoretinopathy in its management. Am J Ophthalmol 1001:188–193Google Scholar
  24. 24.
    Santana M, Wiedemann P, Kirmani M, Minckler DS, Patterson R, Sorgente N, Ryan SJ (1984) Daunomycin in the treatment of experimental proliferative retinopathy: retinal toxicity of intravitreal daunomycin in the rabbit. Graefe's Arch Clin Exp Ophthalmo1 221:210–213Google Scholar
  25. 25.
    Shapiro HM (1988) Practical flow cytometry. Liss, New York, pp 178–181, 276–280Google Scholar
  26. 26.
    Van Bockxmeer FM, Martin CE, Thompson DE, Constable IJ (1985) Taxol for the treatment of proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 26:1140–1147Google Scholar
  27. 27.
    Verdoom C, Renardel de Lavalette VW, Dalma-Weizhausz J, Orr GM, Sorgente N, Ryan SJ (1986) Cellular migration, proliferation, and contraction: an in vitro approach to a clinical problem — proliferative vitreoretinopathy. Arch Ophthalmol 104:1216–1219Google Scholar

Copyright information

© Springer-Verlag 1992

Authors and Affiliations

  • Chung-May Yang
    • 1
  • Karl R. Olsen
    • 1
  • Eleut Hernandez
    • 1
  • Scott W. Cousins
    • 1
  1. 1.Bascom Palmer Eye InstituteUniversity of Miami School of MedicineMiamiUSA

Personalised recommendations